| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | shikonin | GDSC1000 | pan-cancer | AAC | 0.024 | 0.6 |
| mRNA | FSC231 | CTRPv2 | pan-cancer | AAC | 0.044 | 0.6 |
| mRNA | XMD13-2 | GDSC1000 | pan-cancer | AAC | 0.022 | 0.6 |
| mRNA | BRD-K75293299 | CTRPv2 | pan-cancer | AAC | 0.045 | 0.6 |
| mRNA | AUY922 | GDSC1000 | pan-cancer | AAC | 0.025 | 0.6 |
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | GDC-0941 | GDSC1000 | pan-cancer | AAC | 0.023 | 0.6 |
| mRNA | Vandetanib | FIMM | pan-cancer | AAC | -0.13 | 0.6 |
| mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | 0.021 | 0.6 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | 0.023 | 0.6 |